Nonalcoholic Steatohepatitis: A Search for Factual Animal Models
Open accessThe DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Abstract
Nonalcoholic fatty liver disease (NAFLD) is characterized by hepatic steatosis, which occurs in the absence of alcohol abuse. NAFLD can evolve into progressive liver injury and fibrosis in the form of nonalcoholic steatohepatitis (NASH). Several animal models have been developed to attempt to represent the morphological, biochemical, and clinical features of human NASH. The actual review presents a critical analysis of the most commonly used experimental models of NAFLD/NASH development. These models can be classified into genetic, nutritional, and a combination of genetic and nutritional factors. The main genetic models are ob/ob and db/db mutant mice and Zucker rats. The principal nutritional models employ methionine- and choline-deficient, high-fat, high-cholesterol and high-cholate, cafeteria, and high-fructose diets. Currently, associations between high-fructose and various compositions of high-fat diets have been widely studied. Previous studies have encountered significant difficulties in developing animal models capable of reproducing human NASH. Some models produce consistent morphological findings, but the induction method differs significantly compared with the pathophysiology of human NASH. Other models precisely represent the clinical and etiological contexts of this disease but fail to provide accurate histopathological representations mainly in the progression from steatosis to liver fibrosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 The main mechanisms involved in the pathophysiology of the nonalcoholic steatohepatitis (NASH). FFA: free fatty acids; ROS: reactive oxygen species; TG: triglycerides (adapted from Angulo, 2002 [8]).](https://figures.cochat.ai/paper-figures/b42710eb3879438e98ec968c00dfef0a/nonalcoholic-steatohepatitis-a-search-for-factual-animal-models-figure-2.jpg)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The relevance of these models to humans is questionable because they most often essentialize isolated aspects of the human pathophysiology (6).”
From Development of an in vitro human liver system for interrogating nonalcoholic steatohepatitis (2016) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonalcoholic Fatty Liver Disease
Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228
Nonalcoholic fatty liver disease
Adams, L. A. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.045232 · Cited by 1,610
Ahima, R. S., & Flier, J. S. (2000) · Annual Review of Physiology · doi:10.1146/annurev.physiol.62.1.413 · Cited by 1,428
Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis
Feldstein, A. E., Canbay, A., Angulo, P., Taniai, M., Burgart, L. J., Lindor, K. D., & Gores, G. J. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00907-7 · Cited by 1,085
Neuschwander‐Tetri, B. A. (2010) · Hepatology · doi:10.1002/hep.23719 · Cited by 1,077 · cited 1×
“Probably, lipid accumulation occurs in parallel with the generation of lipotoxic metabolites, which are primarily responsible for the progression of liver disease [19, 23].”
Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis
Rolo, A. P., Teodoro, J. S., & Palmeira, C. M. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.10.003 · Cited by 955 · cited 1×
“In hepatic steatosis, the imbalance between scarce endogenous antioxidant reserves and augmented mitochondrial production of free radicals results in oxidative damage to lipids, proteins, and DNA with subsequent cell death [9, 10].”
Bedossa, P., Poitou, C., Veyrie, N., Bouillot, J.-L., Basdevant, A., Paradis, V., Tordjman, J., & Clement, K. (2012) · Hepatology · doi:10.1002/hep.25889 · Cited by 903 · cited 1×
“Another similar method for NASH grading is the SAF system, which comprises a semiquantitative score of steatosis (S), inflammatory activity (A), and fibrosis (F) [7].”
Fructose consumption as a risk factor for non-alcoholic fatty liver disease
Ouyang, X., Cirillo, P., Sautin, Y., McCall, S., Bruchette, J. L., Diehl, A. M., Johnson, R. J., & Abdelmalek, M. F. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.02.011 · Cited by 863 · cited 1×
“In humans, increased levels of fructose consumption, primarily in the form of corn syrup for soft drinks, are associated with increased severity of hepatic steatosis and fibrosis [60, 61].”
Shimomura, I., Hammer, R. E., Richardson, J. A., Ikemoto, S., Bashmakov, Y., Goldstein, J. L., & Brown, M. S. (1998) · Genes & Development · doi:10.1101/gad.12.20.3182 · Cited by 790 · cited 1×
“Similar to some forms of congenital lipodystrophies, the amount of systemic fat tissue is decreased, but the animals present significant hepatic lipid accumulation [27].”
The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome
Lim, J. S., Mietus-Snyder, M., Valente, A., Schwarz, J.-M., & Lustig, R. H. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.41 · Cited by 771 · cited 1×
“No published data on animals demonstrated that administration of fructose alone can alter themetabolic parameters associatedwithNASH, but fructose has been reported to alter potent biochemical properties involved in promoting insulin resistance [66].”
Cited by
Items 101–195 of 195
Acosta-Cota, S. D. J., Aguilar‐Medina, M., Ramos‐Payán, R., Rendón-Maldonado, J. G., Romero-Quintana, J. G., Montes‐Ávila, J., Sarmiento‐Sánchez, J. I., Plazas‐Guerrero, C. G., Vergara-Jiménez, M. D. J., Sánchez‐López, A., et al. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172699 · Cited by 19
MiR-455 targeting SOCS3 improve liver lipid disorders in diabetic mice
Fang, S., Feng, J., Zhang, H., Li, P., Zhang, Y., Zeng, Y., Cai, Y., Lin, X., Xue, Y., & Guan, M. (2020) · Adipocyte · doi:10.1080/21623945.2020.1749495 · Cited by 19
Seo, S. H., Lee, D. H., Lee, Y. S., Cho, K. J., Park, H. J., Lee, H. W., Kim, B. K., Park, J. Y., Kim, D. Y., Ahn, S. H., et al. (2022) · Gastroenterology report · doi:10.1093/gastro/goac037 · Cited by 19
Ejima, C., Kuroda, H., & Ishizaki, S. (2016) · Physiological Reports · doi:10.14814/phy2.13016 · Cited by 19
“Examples of currently available fatty liver disease models include mice fed with a methionine- and choline-deficient diet (MCD), genetically modified animals (such as ob/ob mice, db/db mice, and melanocortin-4 receptor-deficient mice), and forced overfeeding models (Sahai et al. 2004; Deng et al. 2005; Varela-Rey et a…”
BackgroundMorales, M. D. C., Chang, C., Le, V. L., Huang, I., Tsai, I., Shih, H., & Huang, C. (2022) · Cells · doi:10.3390/cells11213425 · Cited by 18
“, murine) diet-induced obesity models have thus been developed, achieved via long-term feeding of high-fat diet (HFD) and high-fructose plus HFD (HFr/HFD) [1,8].”
BackgroundSaleh, D. O., Ahmed, R. F., & Amin, M. M. (2016) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2016-0320 · Cited by 18
Croce, A. C., Ferrigno, A., Berardo, C., Bottiroli, G. F., Vairetti, M., & Pasqua, L. G. D. (2020) · Molecules · doi:10.3390/molecules25061327 · Cited by 18
“The semi quantitative analysis of the AF contribution of these lipid components, in parallel with mass spectrometry data, showed changes in the balance between arachidonic acid and a miscellanea of the other fluorescing free fatty acids in two different models of fatty liver, genetic or induced by a methyl-choline def…”
BackgroundZhao, Q., 杭州310053,中国, 杭., Ge, L., Zhang, K., Chen, H.-F., Zhan, X.-X., Yang, Y. J., Dang, Q.-L., Zheng, Y., Zhou, H., et al. (2020) · 动物学研究 · doi:10.24272/j.issn.2095-8137.2020.051 · Cited by 18
“These findings indicate that the consumption of HFD or HFFCD diets by B6 and D2 mice for 18 weeks led to progressive morphological and histological changes, similar to those observed in human NASH (Sanches et al., 2015).”
BackgroundCroce, A. C., Ferrigno, A., Pasqua, L. G. D., Berardo, C., Piccolini, V. M., Bertone, V., Bottiroli, G. F., & Vairetti, M. (2016) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2016.09.015 · Cited by 17
Hidalgo, I., Nájera, N., Meaney, E., Duran, J. P., Valdespino-Vázquez, M. Y., Villarreal, F. J., & Ceballos, G. M. (2019) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2019.108296 · Cited by 17
Jeon, S. H., Jang, E., Park, G., Lee, Y., Jang, Y. P., Lee, K., Inn, K., Lee, J. K., & Lee, J. (2022) · Nutrients · doi:10.3390/nu14030695 · Cited by 17
“9 g/L) to WD can induce significant hepatic fibrosis [28,29] with metabolic syndromes [30] as well as simple steatosis.”
BackgroundGaskell, H., Ge, X., Désert, R., Das, S., Han, H., Lantvit, D. D., Guzman, G., & Nieto, N. (2019) · Hepatology Communications · doi:10.1002/hep4.1448 · Cited by 16
Quesada‐Vázquez, S., Colom‐Pellicer, M., Navarro‐Masip, È., Aragonès, G., Bas-Prior, J. M. D., Caimari, A., & Escoté, X. (2021) · Nutrients · doi:10.3390/nu13103532 · Cited by 16
“This model had previously shown an aggravating effect of fructose on glucose and lipid metabolism, resulting in hepatic triglyceride accumulation, insulin resistance and a characteristic microvesicular, macrovesicular and steatosis effect similar to those described in humans [20,21].”
ResultDu, J., Ren, W., Zhang, Q., Fu, N., Han, F., Cui, P., Li, W., Kong, L., Zhao, S., Wang, R., et al. (2020) · BioMed Research International · doi:10.1155/2020/4910601 · Cited by 16
“The MCD dietary model has the main advantage of effectively replicating severe steatohepatitis and liver fibrosis in a shorter time than other NASH animal models [25].”
BackgroundEisinger, K., Girke, P., Buechler, C., & Krautbauer, S. (2023) · Mammalian Genome · doi:10.1007/s00335-023-10022-3 · Cited by 15
“OB/ob mice do not express leptin (Sanches et al. 2015), and this may explain why Acta2 protein is not increased.”
Leonurine Inhibits Hepatic Lipid Synthesis to Ameliorate NAFLD via the ADRA1a/AMPK/SCD1 Axis
Fan, W. H., Pan, M., Zheng, C., Shen, H., Pi, D., Song, Q., Zheng, L., Zhen, J., Pan, J., Liu, L., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910855 · Cited by 15
“The HFHSD is commonly employed to induce animal models of NAFLD, recapitulat‑ ing key pathogenic and histological features observed in human NAFLD [24].”
MethodMinocha, S., Villeneuve, D., Praz, V., Moret, C., Lopes, M., Pinatel, D., Rib, L., Guex, N., & Herr, W. (2019) · Molecular and Cellular Biology · doi:10.1128/mcb.00405-18 · Cited by 15
Guinea pigs as models for investigating non-alcoholic fatty liver disease
deOgburn, R. C., Murillo, A. G., & Fernández, M. L. (2016) · Integrative Food Nutrition and Metabolism · doi:10.15761/ifnm.1000149 · Cited by 15
“Phenotypically normal rodents have also been utilized to investigate the effects of dietary composition and individual nutrients on hepatic steatosis [27].”
BackgroundSavari, F., Badavi, M., Rezaie, A., Gharib-Naseri, M. K., & Mard, S. A. (2019) · Free Radical Research · doi:10.1080/10715762.2019.1608982 · Cited by 14
“Although FasL induction has considered as a main role of ROS in NASH progression, FasL and subsequent ligation of Fas has been reported to lead to ROS production and cell death triggering [2,42,43].”
BackgroundTang, M., Wang, X., Wang, S., Xing, C., Xu, Q., Mu, Y., Wu, X., Zhao, Z. A., & Li, F. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116648 · Cited by 13
Pasqua, L. G. D., Berardo, C., Rizzo, V., Richelmi, P., Croce, A. C., Vairetti, M., & Ferrigno, A. (2016) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-016-2758-2 · Cited by 13
Mouse models of nonalcoholic steatohepatitis and their application to new drug development
Phung, H. H., & Lee, C. H. (2022) · Archives of Pharmacal Research · doi:10.1007/s12272-022-01410-5 · Cited by 13
“Examples include uneven development of inflammation and a lack of advanced fibrosis and HCC (Wolf et al. 2014; Sanches et al. 2015).”
BackgroundIbrahim, I. A., Shalaby, A. A., Abdallah, H. M., Zohairy, N. F. E., & Bahr, H. I. (2020) · Advances in Animal and Veterinary Sciences · doi:10.17582/journal.aavs/2020/8.s1.1.10 · Cited by 12
“Similar to our data, Sanches et al. (2015) observed an occurrence of NASH after 12 weeks by feeding on HFD. Administration of EEGS for six weeks, following feeding on HFD, restored liver enzyme activity.”
ResultPilling, D., Karhadkar, T. R., & Gomer, R. H. (2020) · PLoS ONE · doi:10.1371/journal.pone.0244762 · Cited by 12
Rodent models and metabolomics in non-alcoholic fatty liver disease: What can we learn?
Martín-Grau, M., Marrachelli, V. G., & Monleón, D. (2022) · World Journal of Hepatology · doi:10.4254/wjh.v14.i2.304 · Cited by 11
A high-fat diet temporarily renders Sod1-deficient mice resistant to an oxidative insult
Ito, J., Ishii, N., Akihara, R., Lee, J., Kurahashi, T., Homma, T., Kawasaki, R., & Fujii, J. (2016) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2016.10.018 · Cited by 11
The influence of dietary conditions in the effects of resveratrol on hepatic steatosis
Milton‐Laskibar, I., Aguirre, L., Gómez-Zorita, S., Rolo, A. P., & Portillo, M. P. (2020) · Food & Function · doi:10.1039/d0fo01943g · Cited by 11
Yeh, W.-J., Ko, J., Cheng, W.-Y., & Yang, H. (2021) · British Journal Of Nutrition · doi:10.1017/s0007114521003366 · Cited by 10
Miyachi, Y., Yagi, S., Hirata, M., Iwamura, S., Yao, S., Shirai, H., Okumura, S., Iida, T., Ito, T., Uozumi, R., et al. (2020) · Liver Transplantation · doi:10.1002/lt.25814 · Cited by 10
“Despite the efforts of several researchers, there remain some ambiguities over the correspondence of liver steatosis between rats and humans.(44) A study using discarded grafts in liver transplantation would be a bridge connecting the gap.”
BackgroundCasillas-Ramírez, A., Micó-Carnero, M., Sánchez-González, A., Maroto-Serrat, C., Trostchansky, A., & Peralta, C. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1178909 · Cited by 9
“Ln and Ob Zucker rats showed no evidence offibrosis, which is in agreement with reports describing that Ob Zucker rats show resistance to developing fibrosis (58, 59).”
ResultHollenback, D., Hambruch, E., Fink, G., Birkel, M., Schulz, A., Hornberger, M., Liu, K., Staiger, K. M., Krol, H. D., Deuschle, U., et al. (2024) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.123.001900 · Cited by 9
Wu, Y., & Zhou, J. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47030148 · Cited by 9
Preclinical study of the long‐range safety and anti‐inflammatory effects of high‐dose oral meglumine
Manley, K., Bravo‐Nuevo, A., Minton, A. R., Sedano, S., Marcy, A., Reichman, M., Tobia, A. M., Artlett, C. M., Gilmour, S. K., Laury‐Kleintop, L. D., et al. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28492 · Cited by 9
From fatty hepatocytes to impaired bile flow: Matching model systems for liver biology and disease
Kunst, R. F., Niemeijer, M., van der Laan, L. J. W., Spee, B., & van de Graaf, S. F. J. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114173 · Cited by 9
Petyaev, I. M., Dovgalevsky, P. Y., Chalyk, N. E., Klochkov, V. A., Kyle, N. H., & Bashmakov, Y. K. (2018) · International Journal of Chronic Diseases · doi:10.1155/2018/4549614 · Cited by 9
“It should be mentioned that a choline-deficient diet has been used for decades to model NAFLD in animal experiments [29].”
MethodHansen, H. H., Hansen, G., Secher, T., Feigh, M., Veidal, S. S., Fosgerau, K., Jelsing, J., & Vrang, N. (2019) · Springer eBooks · doi:10.1007/978-3-030-11748-1_14 · Cited by 9
Karnawat, K., Parthasarathy, R., Sakhrie, M., Karthik, H., Krishna, K. V., & Balachander, G. M. (2024) · Journal of Materials Chemistry B · doi:10.1039/d4tb00738g · Cited by 8
Quesada‐Vázquez, S., Antolín, A., Colom‐Pellicer, M., Aragonès, G., Herrero, L., Bas-Prior, J. M. D., Caimari, A., & Escoté, X. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314923 · Cited by 8
“To validate this hypothesis, we analyzed the administration of a combination of MC that included NAC, NR, L-carnitine, and betaine, for 1 month in a diet-induced obese mouse model [22,23], focusing on the main pathological characteristics of adipose tissues.”
MethodWeijler, A. M., Schmidinger, B., Kapiotis, S., Laggner, H., & Hermann, M. (2018) · Biochimie · doi:10.1016/j.biochi.2018.02.003 · Cited by 8
The Effects of Warm Acupuncture on the Expression of AMPK in High-Fat Diet-Induced MAFLD Rats
Lee, Y., Choi, D., Park, J., Kim, J. G., Choi, T., & Youn, D. H. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46100687 · Cited by 7
“It affects approximately 30% of the adults in these countries and poses a significant healthcare concern HFD-induced MAFLD models have been recognised as the most suitable animal models for understanding human MAFLD, forming the foundation of MAFLD research [18].”
BackgroundChen, C., Chang, Z., Tsai, F., & Chen, S. (2020) · Immunity Inflammation and Disease · doi:10.1002/iid3.338 · Cited by 7
“In addition, Leptin receptor‐ deficient db/db mice served as a NAFLD/NASH model.(29) Our db/db mouse model results revealed that the macrophage infiltration, increased inflammatory responses, and immune system dysregulation in the liver tissues, is in agreement with the experimental observations by Elinav et al,(30) N…”
ResultMohibi, S., Zhang, J., Chen, M., & Chen, X. (2021) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-21-0239 · Cited by 7
“NASH is one of themost common forms of liver disease in the Western economies as well as a major cause of liver failure resulting in death (30).”
BackgroundLi, T., Gao, S., Zeng, Y. Y., Lin, L., Li, T., Sun, Z., & Yu, Y. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.12.027 · Cited by 6
Pantaleão, A. C. S., de Castro, M. P., Araujo, K. S. F. M., Campos, C. F. F., da Silva, A. L. A., Manso, J. E. F., & Machado, J. C. (2022) · ULTRASONOGRAPHY · doi:10.14366/usg.21182 · Cited by 5
“Moreover, the supplementation of a high-cholesterol and highcholate diet with high-fat levels to animals can cause hepatic morphological alterations found in humans with NASH, as well as 9% body weight loss at the same time [18].”
BackgroundCayuela, N. C., Negreti, G. P., Rasslan, R., Koike, M. K., & Montero, E. F. D. S. (2018) · Acta Cirúrgica Brasileira · doi:10.1590/s0102-865020180090000003 · Cited by 5
Shen, Y., Liu, J., Yao, B., Zhang, Y., Huang, S., Liang, C., Huang, J., Tang, Y., & Wang, X. (2024) · Toxicology Letters · doi:10.1016/j.toxlet.2024.04.010 · Cited by 5
Zhou, Y., Feng, Y., Yang, L., Zheng, P., Hang, L., Jiang, F., Yuan, J., & Zhu, L. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1022172 · Cited by 5
“, 2017) and more hepatic lipids accumulates in BALB/ c male mice than in C57BL/6 male mice (Sanches et al., 2015) upon long-term HFD feeding.”
BackgroundCaio de Souza, L. E. V. Y., Costa, F., Faria, D. D. P., Stefano, J. T., Cogliati, B., & de Oliveira, C. P. M. S. (2019) · Arquivos de Gastroenterologia · doi:10.1590/s0004-2803.201900000-02 · Cited by 5
“Several models were developed with this purpose despite none of these models is widely accepted yet(8,9).”
BackgroundComparison and Characteristics of MASLD Mouse Models
Wei, L., 高春辰, & Qin, H. (2026) · Biomedicines · doi:10.3390/biomedicines14040895 · Cited by 4
“Several studies support that leptin deficiency reduces extracellular matrix production even under profibrotic stimuli, highlighting the essential role of this hormone in fibrogenesis [66].”
Terayama, Y., Nakamura, S., Mekada, K., Matsuura, T., & Ozaki, K. (2022) · Laboratory Investigation · doi:10.1038/s41374-022-00732-8 · Cited by 4
Costa, F., Stefano, J. T., Faria, D. D. P., Caio de Souza, L. E. V. Y., Chammas, M. C., Carneiro, C. D. G., Pereira, I. V. A., Cogliati, B., Carrilho, F. J., & de Oliveira, C. P. M. S. (2018) · Hepatoma Research · doi:10.20517/2394-5079.2018.06 · Cited by 4
“There are many animal models for HCC that include genetically altered animals and orthotopic tumor implantation, however they are not ideal to replicate NAFLD as they do not exhibit liver and metabolic changes([7,10]).”
BackgroundStygar, D. M., Sawczyn, T., Dulska, A., Chełmecka, E., Mielańczyk, Ł., Matysiak, N., Kukla, M., Idzik, M., Augustyniak, J., Gabriel, A., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-87293-w · Cited by 4
Paediatrician’s guide to epigenetics
Byrne, L., & Drake, A. J. (2019) · Archives of Disease in Childhood · doi:10.1136/archdischild-2018-316054 · Cited by 4
Beneficial Effects of Ketogenic Diet on Nonalcoholic Steatohepatitis in Obese Mice Model
Charlot, A., Charles, A., Georg, I., Goupilleau, F., Debrut, L., Pizzimenti, M., Mallard, J., Pagano, A. F., Gény, B., & Zoll, J. (2022) · International Electronic Conference on Nutrients (IECN) · doi:10.3390/iecn2022-12368 · Cited by 3
“The histological staining with Hematoxylin and eosin revealed a severe steatosis associated with hepatocellular ballooning and lobular inflammation These results are according to the literature in NAFLD mice models, and confirmed the NASH diagnosis [15].”
ResultZhong, H., Liu, H., Jiang, Z., & Huang, W. (2024) · European Journal of Lipid Science and Technology · doi:10.1002/ejlt.202300048 · Cited by 3
Steatosis Alters the Activity of Hepatocyte Membrane Transporters in Obese Rats
Pastor, C. M., & Vilgrain, V. (2021) · Cells · doi:10.3390/cells10102733 · Cited by 3
“Experimental nonalcoholic fatty livers can be investigated in Zucker fatty (fa/fa) rats [7,8].”
Background[Research progress on non-alcoholic fatty liver disease animal models].
Yang, H., Gao, G. D., Liu, C. L., Rui, F., Guo, Z., Ren, W., & Li, J. (2021) · Zhonghua ganzangbing zazhi · doi:10.3760/cma.j.cn501113-20191209-00452 · Cited by 2
ANTIDIABETIC EFFECT TEST OF CENTELLA ASIATICA EXTRACT IN HYPERCHOLESTEROLEMIA RAT MODELS
Nafiisah, N., Gumilas, N. S. A., & Harini, I. M. (2024) · Jurnal Widya Medika · doi:10.33508/jwm.v10i2.6031 · Cited by 2
Singgih, I. M. G., Yustisia, I., Santoso, A., Aminuddin, A., Kurniawan, L. B., & Kasim, H. (2021) · Indonesian Journal of Human Nutrition · doi:10.21776/ub.ijhn.2021.008.02.3 · Cited by 2
“metabolisme glukosa dan lipid, mengakibatkan peningkatan deposisi jaringan adiposa viseral, akumulasi trigliserida hati dan resistensi insulin, sehingga penggunaan gabungan diet tinggi lemak dan fruktosa diusulkan.[6] Fruktosa dapat ditambahkan ke dalam air minum saat hewan diberi makan HFD atau dapat dimasukkan ke da…”
BackgroundCayuela, N. C. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2018.tde-11092018-152539 · Cited by 2
Signal Transduction in Disease
Ganey, P. E., & Misek, S. A. (2019) · Wiley eBooks · doi:10.1002/9781119060208.ch4 · Cited by 1
Resveratrol and Protection in Hepatic Steatosis: Antioxidant Effects
Fernández‐Quintela, A., González, M. A., Aguirre, L., Milton‐Laskibar, I., Léniz, A., & Portillo, M. P. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-803951-9.00017-3 · Cited by 1
La lipidose hépatique chez le cochon d’inde (cavia porcellus)
Bodin, P. (2017) · HAL · Cited by 1
Therapeutic Approaches for Nonalcoholic Steatohepatitis ( NASH )
Glatthar, R., & Arch, R. H. (2021) · Wiley eBooks · doi:10.1002/0471266949.bmc274 · Cited by 1
Zoubek, M. E. (2021) · Research Publications (Maastricht University) · doi:10.26481/dis.20210929mz · Cited by 1
Costa, F. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2017.tde-06032017-103057
Role of high-fructose diet in experimental induction of nonalcoholic steatohepatitis in rats
Sheikh, A. F. A.-A. E., Hassan, S. E.-H., El‐Batch, M., & Zakareia, S. (2017) · Tanta Medical Journal · doi:10.4103/tmj.tmj_33_16
Redução da produção de H2S no fígado de camundongos alimentados com dieta hiperlipídica.
Barbosa, B. L. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.42.2019.tde-18092019-155851
Satyavathi, G., Srinivas, Y., & Malleswari (2015)
Bellentani, S., & Rosso, N. (2017) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.731388417.793537618
Swinney, D. C. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.737198406.793576929
Histopathological Evaluation of Steatohepatitis in Animal Experiments
Takahashi, Y., Dungubat, E., Kusano, H., & Fukusato, T. (2022) · Methods and protocols in food science · doi:10.1007/978-1-0716-2345-9_4
Non-alcoholic Fatty Liver Disease: Pathology, Disease Models and Therapies
Wu, Z. (2023) · Highlights in Science Engineering and Technology · doi:10.54097/hset.v36i.5702
Dietary animal models of non-alcoholic fatty liver disease: A comprehensive review
Kalia, S., Kaur, A., Gill, N. S., & Kaur, S. (2025) · International Journal of Pharmacology and Clinical Research · doi:10.33545/26647613.2025.v7.i1d.82
Impact of fructose consumption on metabolic and hypertrophy markers in mice liver and heart
Tapia, G., Luna, R., González, J., Bravo, C., D’Espessailles, A., Abarca, C., Jara, J., Sánchez, G., & Olmedo, I. (2025) · Revista chilena de nutrición · doi:10.64159/rchnut-52-3-3
Modelos experimentales de esteatosis hepática no alcohólica.
Fernández García, C., & Güemes Sánchez, A. T. (2015) · Zaguan (Universidad de Zaragoza)
Tratamiento farmacológico de la esteatosis hepática.
Bureu Calleja, B., & Güemes Sánchez, A. (2017) · Zaguan (Universidad de Zaragoza)
Passos, E. F. D. (2023) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/0fta-bj54
Henkel, J. (2025) · EPub Bayreuth (University of Bayreuth) · doi:10.15495/epub_ubt_00008603
Einfluss einer NASH-induzierenden Diät und Ausdauertraining im Rattenmodell
Buchheim-Dieckow, K. (2025) · publish.UP (University of Potsdam) · doi:10.25932/publishup-69352
Marcella, M., Wihandani, D. M., Artini, I. G. A., Sumadi, I. W. J., Dwipayana, I. M. P., & Sriwidyani, N. P. (2026) · JPSCR Journal of Pharmaceutical Science and Clinical Research · doi:10.20961/jpscr.v10i3.100142
“Fructose disrupts glucose and lipid metabolism, promotes visceral fat accumulation, and induces insulin resistance, leading to increased hepatic triglycerides and an increased risk of cardiovascular disease (Malik & Hu, 2015; Sanches et al., 2015).”
Research progress on animal models of metabolic dysfunction-associated fatty liver disease
Lin-Yun, Z. H. A. O., Zhang, X., Zi-Meng, X. I., ZHANG, Q., Chun-Li, M. A., & Bao, Y. (2026) · Shengming kexue · doi:10.3724/cbls.2026017
“…。近年开发的 复合模型 ( 如高脂高糖高胆固醇 + 四氯化碳腹腔注射 ) 通过整合代谢打击与直接肝损伤 , 将 NASH 纤维化诱 导时间缩短至 8~12 周 , 同时保持代谢综合征表型 ( 肥 胖率 100% 、 空腹血糖受损发生率 75% ), 为抗纤维化 药物研发提供了更高效的实验工具 [ 21 ] 时需列明具体成分或商品编号 [ 22 ] 。该模型通常旨 在模拟高糖高脂饮食对人类代谢健康的影响 , 但剔 除蛋氨酸和胆碱可加速肝脏脂质代谢紊乱的发生 , 从而快速诱导小鼠出现肝脏脂肪变性 、 炎症及纤维 化等病理特征 [ 23 ] 。具体而言 , 蛋氨酸缺乏时肝细胞…”
Rôle de l’obésité et de l’insulino-résistance sur la stéatose hépatique non alcoolique
Dergaoui, R., & Frid, S. F. (2022) · Dépôt Institutionnel de lUniversité de Tlemcen
安田, 大. (2021) · Institutional Repositories DataBase (IRDB) · doi:10.32129/00000193
Roles of hepatic group 1 ILC during the early stages of non-alcoholic fatty liver diseases
Perchet, T. (2018) · theses.fr (ABES) · doi:10.70675/bc8aaf99z6c7ez43a6z9188z1b907d1dc9dc
Diversité des macrophages dans un modèle murin de stéatohépatite non alcoolique
Tran, S. (2019) · theses.fr (ABES) · doi:10.70675/22efc884z2788z43fazabc1zaeb115ea6833
Examining the link between the ductular reaction and fibrosis in fatty liver disease
Boyd, A. (2025) · University of Birmingham Institutional Research Archive (University of Birmingham)
La signalisation du TGFβ dans le carcinome hépatocellulaire au niveau fondamental et translationnel
Desoteux, M. (2023) · theses.fr (ABES) · doi:10.70675/57405ceaz3de8z4bb2z970ez8afb349427f3
Metadata
- Authors
- Sanches, S. C. L., Ramalho, L. N. Z., Augusto, M. J., da Silva, D. M., & Ramalho, F. S.
- Affiliations
- Universidade de São Paulo (BR)
- Department of Pathology, School of Medicine of Ribeirão Preto, University of São Paulo, Avenida Bandeirantes 3900, Monte Alegre, 14049-900 Ribeirão Preto, SP, Brazil
- Corresponding author
- Ramalho, Fernando Silva
- Venue
- BioMed Research International
- Publisher
- Wiley
- Published
- 2015
- Volume
- 2015
- Pages
- 1-13
- ISSN
- 1110-7243 (ISSN-L)
- 2314-6133
- 2314-6141
- PMC
- PMC4433658
- OpenAlex
- W1969807612
- Cited by
- 174
- References
- 74
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 10 · 2023: 8 · 2022: 15 · 2021: 16 · 2020: 21 · 2019: 30 · 2018: 24 · 2017: 19 · 2016: 24 · 2015: 2
- FWCI
- 2.99
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- BioMed Research International (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (160028/2012-4)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- nonalcoholic steatohepatitis, non-alcoholic fatty liver disease, animal models, hepatic steatosis, liver fibrosis, ob/ob mice, db/db mice, Zucker rats, methionine-choline-deficient diet, high-fat diet, high-fructose diet, cafeteria diet, high-cholesterol diet, genetic models, nutritional models
- MeSH terms
- Animals, Disease Models, Animal, Humans, Liver Cirrhosis, Disease Progression, Mice, Rats, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.